RMD Stock Cash Flow Statements

ResMed Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

ResMed Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-06-30	2020-03-31	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31

cash flows from operating activities:
net income	379,705,000	365,041,000	344,622,000	311,355,000	292,236,000	300,493,000	208,800,000	219,422,000	229,664,000	232,500,000	224,914,000	210,478,000	195,061,000	179,012,000	201,751,000	203,613,000	195,100,000	-78,481,000	177,835,000	163,137,000	68,801,000	105,414,000	124,640,000	105,737,000	109,811,000	110,126,000	9,526,000	86,125,000	101,612,000	87,823,000	76,742,000	76,107,000	93,032,000	88,458,000	90,516,000	80,403,000	87,462,000	90,984,000	91,180,000	83,260,000	87,738,000	89,969,000	86,636,000	80,930,000	73,013,000	84,913,000	77,942,000	71,265,000	76,847,000	64,613,000	62,872,000	50,518,000	58,472,000	53,350,000	58,456,000	56,708,000	53,166,000	48,834,000	45,983,000	42,102,000	45,370,000	39,199,000	33,853,000	28,026,000	29,634,000	29,683,000	26,861,000	24,125,000	27,673,000	-15,365,000	28,995,000	24,999,000	23,093,000	26,362,000	22,314,000	16,442,000	15,578,000	17,877,000	17,404,000	13,926,000	15,855,000	15,029,000
adjustment to reconcile net income to net cash from operating activities:
depreciation and amortization	63,628,000	43,676,000	46,439,000	44,730,000	43,678,000	43,474,000	44,784,000	44,934,000	46,760,000	44,356,000	37,767,000	36,273,000	37,411,000	42,307,000	40,789,000	39,102,000	36,724,000	39,988,000	38,509,000	39,264,000	42,592,000	41,750,000	36,029,000	30,424,000	31,704,000	29,311,000	29,374,000	29,571,000	28,168,000	28,485,000	27,729,000	27,775,000	27,022,000	19,907,000	21,517,000	18,403,000	17,746,000	17,859,000	18,869,000	18,582,000	19,823,000	17,181,000	18,580,000	17,870,000	19,659,000	20,674,000	19,297,000	18,650,000	22,426,000	20,026,000	22,994,000	20,410,000	19,508,000	18,120,000	17,346,000	15,642,000	15,473,000	16,397,000	15,599,000	14,094,000	14,854,000	12,532,000	11,739,000	14,280,000	16,508,000	14,695,000	13,826,000	14,291,000	13,102,000	12,220,000	12,000,000	10,626,000	11,071,000	10,663,000	9,669,000	9,567,000	8,766,000	7,281,000	6,624,000	5,621,000	5,094,000	4,552,000
amortization of right-of-use assets	10,660,000	8,235,000	9,463,000	8,980,000	11,077,000	11,168,000	8,586,000	8,508,000	8,439,000	8,434,000	7,772,000	7,761,000	7,596,000	9,302,000	8,817,000	8,517,000	8,955,000	7,894,000
stock-based compensation costs	24,751,000	24,120,000	22,634,000	20,156,000	21,392,000	20,442,000	19,840,000	18,510,000	19,927,000	17,832,000	16,464,000	16,919,000	15,992,000	15,861,000	16,101,000	17,303,000	16,895,000	15,591,000	16,138,000	14,112,000	14,217,000	12,845,000	12,534,000	12,477,000	12,479,000	11,975,000	12,010,000	11,948,000	11,662,000	11,461,000	10,753,000	12,049,000	11,629,000	10,938,000	11,458,000	12,383,000	13,053,000	11,718,000	11,717,000	11,367,000	10,778,000	11,219,000	10,644,000	10,816,000	10,499,000	10,215,000	9,522,000	7,921,000	8,141,000	7,855,000	7,385,000	7,205,000	7,613,000	6,693,000	8,153,000	8,350,000	7,884,000	8,038,000	7,289,000	6,523,000	6,431,000	6,662,000	6,842,000	5,580,000	5,329,000	5,593,000	5,273,000	4,546,000	4,535,000	4,731,000	4,615,000	3,624,000	3,925,000	3,667,000	4,322,000	3,391,000
restructuring expenses																	0	0
gain on insurance recoveries
changes in operating assets and liabilities:
accounts receivable	-5,215,000	-40,033,000	-67,853,000	36,417,000	-57,523,000	-56,486,000	-26,803,000	6,534,000	-18,059,000	-12,629,000	-19,585,000	-56,238,000	-78,812,000	15,689,000	48,765,000	33,704,000	-89,296,000	-20,640,000	88,523,000	-33,865,000	-16,531,000	-33,848,000	12,024,000	20,342,000	7,065,000	-13,276,000	-49,462,000	23,317,000	-30,811,000	-25,713,000	-43,287,000	36,207,000	-30,105,000	-21,735,000	-5,965,000	30,498,000	-13,445,000	-25,881,000	-9,737,000	20,804,000	-22,235,000	-34,934,000	-18,207,000	40,268,000	-28,053,000	-14,972,000	-12,639,000	18,397,000	-20,050,000	-26,553,000	12,020,000	14,290,000	-19,310,000	-13,209,000	-9,995,000	11,715,000	-11,514,000	-18,885,000	-1,569,000	7,226,000	-8,299,000	-13,459,000	-15,705,000	4,566,000	-13,964,000	-4,048,000	-1,943,000	3,872,000	-14,026,000	-8,591,000	-10,213,000	7,218,000	-8,087,000	-10,962,000	-10,007,000	769,000	-11,508,000	-12,540,000	-3,999,000	51,000	-3,890,000	-6,435,000
inventories	-32,133,000	29,863,000	-7,641,000	-70,254,000	8,909,000	86,199,000	50,184,000	26,911,000	6,258,000	-21,975,000	-86,020,000	-147,096,000	-102,205,000	-70,227,000	-83,273,000	-55,976,000	26,439,000	-14,181,000	-47,317,000	5,730,000	-29,186,000	-24,432,000	-14,909,000	-15,661,000	12,640,000	9,614,000	6,182,000	-26,942,000	-3,453,000	-2,042,000	-8,031,000	-28,073,000	4,480,000	17,261,000	25,945,000	-17,194,000	-18,731,000	-16,387,000	-26,509,000	-37,897,000	-116,000	13,899,000	-2,787,000	-26,847,000	17,280,000	26,360,000	201,000	-16,698,000	6,032,000	3,838,000	4,693,000	4,243,000	7,815,000	12,615,000	3,519,000	-12,555,000	2,634,000	-15,438,000	-7,601,000	-11,867,000	-35,000	-9,094,000	-4,944,000	-2,068,000	8,541,000	4,723,000	584,000	-4,243,000	2,780,000	-14,258,000	-13,801,000	-5,188,000	-7,298,000	-561,000	-6,630,000	-10,552,000	-8,195,000	-7,927,000	-2,433,000	-4,007,000	-783,000	-755,000
prepaid expenses, net deferred income taxes and other current assets	47,017,000	79,358,000	-43,623,000	-123,000	-16,237,000	-24,386,000	-32,575,000	-42,015,000	-51,518,000	-19,961,000	-29,862,000	-36,784,000	-40,132,000	-106,588,000	-6,998,000	-14,391,000	-17,118,000	-11,161,000	9,725,000	-1,906,000	-30,122,000	9,469,000	-19,219,000	-7,703,000	-88,394,000	-69,474,000	12,550,000	-15,408,000	9,297,000	-13,357,000	3,918,000	-19,115,000	12,022,000	-14,299,000	17,924,000	-3,526,000	-19,362,000	822,000	10,859,000	-15,168,000	9,834,000	-6,114,000	6,545,000	-4,451,000	-24,797,000	-1,131,000	-263,000	-2,487,000		-5,475,000	9,470,000	-31,036,000		9,260,000	-1,942,000	5,421,000		-5,982,000	-5,247,000	-254,000		-105,000	-4,601,000	4,516,000		284,000				-19,978,000				-985,000
accounts payable, accrued expenses and other																	52,589,000	257,467,000	33,877,000	31,626,000	79,393,000	18,519,000	-26,165,000	-99,025,000	36,110,000	69,051,000	111,079,000	-15,590,000		-10,981,000
net cash from operating activities	538,766,000	578,661,000	308,623,000	325,538,000	440,114,000	402,031,000	272,832,000	286,283,000	237,436,000	282,565,000			79,486,000	117,439,000			226,525,000	196,278,000	330,265,000	239,695,000	141,818,000	139,646,000	129,468,000	48,119,000	129,416,000	149,076,000	132,551,000	93,983,000	140,313,000	67,598,000	119,899,000	86,243,000	156,272,000	122,149,000	147,440,000	122,072,000	99,701,000	90,941,000	106,002,000	86,536,000	115,583,000	101,095,000	84,165,000	90,425,000	123,922,000	107,000,000	93,647,000	78,254,000	96,977,000	86,026,000	110,633,000	89,523,000	74,328,000	81,408,000	68,311,000	59,143,000	58,962,000	53,542,000	11,568,000	64,141,000	70,230,000	44,248,000	56,493,000	67,906,000	56,852,000	33,934,000	18,922,000	28,128,000	27,106,000	20,305,000	17,563,000	26,132,000	35,310,000	32,831,000	14,947,000	15,940,000	21,283,000	10,866,000	22,312,000	16,618,000	23,333,000	27,211,000
capex	-30,585,000	-20,796,000	-20,644,000	-17,840,000	-24,881,000	-21,191,000	-23,353,000	-30,035,000	-34,449,000	-28,817,000			-28,643,000	-48,445,000			-27,907,000	-26,362,000	-17,970,000	-29,589,000	-22,203,000	-15,082,000	-18,431,000	-12,994,000	-17,620,000	-12,961,000	-15,970,000	-16,030,000	-18,362,000	-14,610,000	-14,687,000	-14,560,000	-14,401,000	-13,199,000	-14,531,000	-16,403,000	-12,236,000	-10,591,000	-18,994,000	-20,681,000	-18,512,000	-17,784,000	-19,674,000	-16,752,000	-16,003,000	-19,941,000	-13,804,000	-13,831,000	-12,068,000	-9,878,000	-12,311,000	-12,878,000	-17,446,000	-16,044,000	-17,786,000	-15,333,000	-16,322,000	-11,940,000	-14,515,000	-14,078,000	-25,839,000	-21,992,000	-27,398,000	-34,463,000	-18,194,000	-17,291,000	-21,927,000	-18,367,000	-17,429,000	-15,030,000	-16,951,000	-28,146,000	-23,614,000	-15,975,000	-23,587,000	-39,573,000	-13,538,000	-10,195,000	-8,504,000	-7,454,000	-11,247,000	-18,964,000
free cash flows	508,181,000	557,865,000	287,979,000	307,698,000	415,233,000	380,840,000	249,479,000	256,248,000	202,987,000	253,748,000			50,843,000	68,994,000			198,618,000	169,916,000	312,295,000	210,106,000	119,615,000	124,564,000	111,037,000	35,125,000	111,796,000	136,115,000	116,581,000	77,953,000	121,951,000	52,988,000	105,212,000	71,683,000	141,871,000	108,950,000	132,909,000	105,669,000	87,465,000	80,350,000	87,008,000	65,855,000	97,071,000	83,311,000	64,491,000	73,673,000	107,919,000	87,059,000	79,843,000	64,423,000	84,909,000	76,148,000	98,322,000	76,645,000	56,882,000	65,364,000	50,525,000	43,810,000	42,640,000	41,602,000	-2,947,000	50,063,000	44,391,000	22,256,000	29,095,000	33,443,000	38,658,000	16,643,000	-3,005,000	9,761,000	9,677,000	5,275,000	612,000	-2,014,000	11,696,000	16,856,000	-8,640,000	-23,633,000	7,745,000	671,000	13,808,000	9,164,000	12,086,000	8,247,000
cash flows from investing activities:
purchases of property, plant and equipment	-30,585,000	-20,796,000	-20,644,000	-17,840,000	-24,881,000	-21,191,000	-23,353,000	-30,035,000	-34,449,000	-28,817,000	-27,350,000	-29,056,000	-28,643,000	-48,445,000	-30,407,000	-27,340,000	-27,907,000	-26,362,000	-17,970,000	-29,589,000	-22,203,000	-15,082,000	-18,431,000	-12,994,000	-17,620,000	-12,961,000	-15,970,000	-16,030,000	-18,362,000	-14,610,000	-14,687,000	-14,560,000	-14,401,000	-13,199,000	-14,531,000	-16,403,000	-12,236,000	-10,591,000	-18,994,000	-20,681,000	-18,512,000	-17,784,000	-19,674,000	-16,752,000	-16,003,000	-19,941,000	-13,804,000	-13,831,000	-12,068,000	-9,878,000	-12,311,000	-12,878,000	-17,446,000	-16,044,000	-17,786,000	-15,333,000	-16,322,000	-11,940,000	-14,515,000	-14,078,000	-25,839,000	-21,992,000	-27,398,000	-34,463,000	-18,194,000	-17,291,000	-21,927,000	-18,367,000	-17,429,000	-15,030,000	-16,951,000	-28,146,000	-23,614,000	-15,975,000	-23,587,000	-39,573,000	-13,538,000	-10,195,000	-8,504,000	-7,454,000	-11,247,000	-18,964,000
patent registration costs																	-2,965,000	-2,782,000	-3,217,000	-2,520,000	-2,076,000	-1,913,000	-2,032,000	-2,611,000	-2,133,000	-2,119,000	-2,382,000	-2,242,000	-2,277,000	-2,377,000	-2,132,000	-2,471,000	-2,404,000	-1,989,000	-2,479,000	-2,423,000	-2,333,000	-2,299,000	-2,444,000	-2,366,000	-2,743,000	-2,348,000	-1,664,000	-1,679,000	-2,350,000	-1,052,000	-3,766,000	-1,035,000	-1,466,000	-1,725,000	-2,095,000	-1,686,000	-1,439,000	-1,383,000	-2,145,000	-1,464,000	-1,308,000	-893,000	-1,257,000	-1,328,000	-1,087,000	-1,173,000	-1,152,000	-1,116,000	-1,281,000	-1,420,000	-1,654,000	-1,284,000	-1,265,000	-687,000	-1,252,000	-761,000	-702,000	-936,000	-767,000	-710,000	-747,000	-788,000	-576,000	-708,000	-654,000	-380,000
business acquisitions, net of cash acquired	-138,578,000	0			-19,697,000	-3,079,000	-7,505,000	-103,183,000	-1,524,000	0	-992,125,000	-19,100,000	-6,869,000	0			-8,363,000	-30,267,000	0	-24,487,000	182,000	-212,316,000	-612,810,000	-126,439,000	-420,000				-3,880,000	-210,000	-94,000	-3,090,000	-799,219,000	-90,527,000			-2,451,000	-9,175,000	-10,463,000	-7,318,000	-680,000	0			0	0	0	-5,418,000	0	-1,399,000	0	-51,923,000	0	-1,300,000
purchases of investments	-2,013,000	-2,053,000	-1,000,000	-1,350,000	-3,073,000	-2,387,000	-3,625,000	-3,680,000	-2,500,000	-12,597,000	-12,841,000	-4,291,000	-4,110,000	-4,250,000	-5,764,000	-6,600,000	-1,750,000	-5,592,000	0	-9,775,000	-15,625,000	-3,125,000
proceeds from exits of investments	250,000	0	250,000	4,128,000	750,000	0	0	250,000
proceeds / (payments) on maturity of foreign currency contracts					1,834,000	-4,577,000
net cash from investing activities	-133,713,000	-31,786,000	-36,692,000	2,146,000	-46,509,000	-33,152,000	-41,143,000	-148,980,000	-46,523,000	-28,104,000	-1,026,412,000	-58,806,000	-55,241,000	-49,495,000	-83,308,000	-41,874,000	-48,072,000	-58,619,000	-3,407,000	-99,612,000	-43,888,000	-225,407,000	-658,222,000	-148,189,000	-38,526,000	-19,619,000	-28,255,000	-15,424,000	-31,280,000	-17,918,000	-19,523,000	-13,169,000	-818,159,000	-83,733,000	-161,113,000	-62,749,000	-23,476,000	-18,997,000	-58,995,000	-41,603,000	-22,836,000	-23,201,000	-27,358,000	-21,592,000	-26,485,000	-21,004,000	-15,528,000	-14,983,000	-8,151,000	-5,811,000	-15,968,000	-71,685,000	-15,137,000	-14,596,000	-15,870,000	-30,908,000	-14,299,000	-9,407,000	-21,209,000	-13,396,000	-21,662,000	-22,631,000	-30,069,000	-34,937,000	-14,849,000	11,153,000	-7,380,000	-26,777,000	-19,314,000	-15,118,000	-20,773,000	-50,212,000	-22,792,000	-18,921,000	-30,160,000	-48,001,000	-16,727,000	-36,652,000	-34,340,000	941,000	-11,151,000	-23,044,000
cash flows from financing activities:
proceeds from issuance of common stock	30,156,000	9,023,000	26,877,000	8,383,000	27,695,000	4,892,000	19,524,000	983,000	23,493,000	983,000	22,056,000	2,610,000	21,115,000	2,814,000	19,101,000	4,354,000	19,031,000	145,000	22,070,000	1,815,000	21,381,000	2,562,000	12,395,000	389,000	13,729,000	3,016,000	2,972,000	3,615,000	14,906,000	5,439,000	3,486,000	6,330,000	10,757,000	8,871,000	3,714,000	4,352,000	15,630,000	13,245,000	5,001,000	4,930,000	17,730,000	5,488,000	3,666,000	6,470,000	19,356,000	16,575,000	11,641,000	21,667,000	25,053,000	17,503,000	10,581,000	9,354,000	20,288,000	20,620,000	39,986,000	13,756,000	29,871,000	26,842,000	25,126,000	13,383,000	4,972,000	7,181,000	3,636,000	9,103,000	4,733,000	3,072,000	8,205,000	5,617,000	5,582,000	14,821,000	13,503,000	4,354,000	7,660,000	8,947,000	8,861,000	8,921,000	7,526,000	21,723,000	6,410,000	3,767,000	5,409,000	3,293,000
taxes paid related to net share settlement of equity awards	-590,000	-364,000	-16,734,000	-389,000	-421,000	-314,000	-7,797,000	-225,000	-334,000	-584,000	-29,654,000	-59,000	-128,000	-2,253,000	-49,830,000	-195,000	-271,000	-3,431,000	-955,000	-4,015,000	-224,000	-540,000
purchases of treasury stock	-100,008,000	-75,026,000	-74,986,000	-50,005,000	-50,004,000	-50,000,000															0	0	-3,445,000	-19,399,000	-25,904,000	-19,356,000							0	0	-44,201,000	-57,857,000	-57,005,000	-19,240,000	-37,252,000	-46,803,000	-32,771,000	-75,806,000	-70,770,000	-22,822,000	-70,919,000	-67,288,000	-39,956,000	-8,095,000	-91,715,000	-65,057,000	-114,274,000	-121,697,000	-62,447,000	-59,534,000	-18,724,000	-22,637,000	-54,550,000	-10,703,000	-32,368,000	-33,461,000	-12,989,000	-26,627,000	-1,961,000	-27,016,000	-48,752,000	-23,246,000	-8,058,000	-16,501,000
payments of business combination contingent consideration	0	0	0	-855,000	0	0	0	-1,293,000	-2,045,000								0		0	0	-261,000	-218,000	-190,000	-240,000	-281,000
acquisition of consolidated subsidiary
proceeds from borrowings, net of borrowing costs					0	0	0	105,000,000	0	0	1,020,000,000	50,000,000	128,000,000	0	10,000,000	150,000,000	0	35,000,000	200,000,000	260,000,000	105,000,000	323,000,000	788,230,000	303,000,000	230,000,000	70,000,000	0	50,000,000	100,000,000	275,000,000	50,000,000	25,000,000	830,000,000	110,000,000	0	200,000,000	20,000,000	11,000,000	74,000,000	75,000,000	49,996,000	14,930,000							85,000,000				19,735,000												24,000,000	5,000,000			1,000	0			67,128,000	5,000,000	20,000,000	10,000,000
repayment of borrowings	-5,000,000	0	-5,000,000	-30,000,000	-300,000,000	-220,000,000	-130,000,000	-185,000,000	-145,000,000	-215,000,000	-15,000,000	-30,000,000	-30,000,000	0			-76,000,000	-130,000,000	-401,000,000	-183,000,000	-170,351,000	-188,596,000	-266,665,000	-86,133,000	-756,242,000	-280,000,000	0	-110,000,000	-190,000,000	-275,000,000	-55,000,000	-25,000,000	-90,602,000	-92,932,000	-100,152,000	-8,000	-180,009,000	-1,508,000	-9,000	-10,000	-145,006,000	-55,010,000	-360,010,000	-9,000	-100,045,000	-9,000	-9,000	-158,000	-70,098,000	-494,000	-2,937,000	-52,456,000	-72,000	-64,137,000	-29,382,000	-30,000,000	-20,000,000	-175,000			0	-523,000	-34,142,000	-3,770,000	-18,532,000	-13,000,000	0	-5,108,000	-60,000
dividends paid	-77,590,000	-77,704,000	-77,695,000	-77,891,000	-70,553,000	-70,492,000	-70,678,000	-70,597,000	-64,705,000	-64,640,000	-64,500,000	-64,431,000	-61,488,000	-61,419,000	-61,245,000	-61,189,000	-56,796,000	-56,752,000	-56,483,000	-56,408,000	-53,120,000
net cash from financing activities	-163,887,000	-144,071,000	-147,538,000	-150,757,000	-393,283,000	-335,914,000	-238,958,000	-151,132,000					57,499,000	-60,858,000			-114,036,000	-158,538,000	-236,368,000	18,392,000	-97,575,000	83,183,000	450,211,000	144,824,000	-588,668,000	-276,519,000	-55,424,000	-106,083,000	-121,894,000	-52,924,000			694,739,000	-13,539,000	-175,560,000	106,944,000	-236,563,000	-26,039,000	10,776,000	-3,965,000	-140,235,000	-144,433,000	-22,608,000	9,960,000	-116,472,000	-30,435,000	-14,710,000	7,690,000																			16,887,000	-14,935,000	4,539,000	-1,259,000	28,916,000	5,900,000	36,060,000	14,192,000	27,603,000	19,912,000	4,261,000	21,723,000	6,410,000	-7,198,000	5,407,000	3,293,000
effect of exchange rate changes on cash	35,573,000	7,963,000	-28,810,000	11,073,000	129,000	-5,302,000	8,416,000	-4,962,000	-2,325,000	-209,000	10,910,000	-10,523,000	-9,803,000	207,000	-270,000	-4,568,000	226,000	-4,351,000	19,805,000	-9,709,000	260,000	-377,000	-2,177,000	-3,267,000	-17,802,000	-7,556,000	-1,075,000	16,691,000	7,486,000	42,408,000	-45,887,000	17,198,000	-19,913,000	34,814,000	25,984,000	-61,463,000	11,262,000	-60,275,000	-58,782,000	-65,004,000	14,655,000	32,427,000	-38,098,000	21,733,000	-117,615,000	-1,143,000	4,242,000	10,127,000	-8,463,000	8,586,000	28,811,000	-59,099,000	23,924,000	10,031,000	25,723,000	59,477,000	-37,171,000	6,427,000	5,659,000	29,438,000	47,542,000	-6,143,000	-25,916,000	-52,360,000	9,646,000	11,548,000	-1,240,000	7,106,000	5,355,000	3,510,000	5,807,000	-209,000	4,805,000	-2,223,000	-1,837,000	-307,000	-3,332,000	-2,305,000	7,066,000	2,352,000	-3,250,000	-354,000
net increase in cash and cash equivalents	276,739,000	410,767,000	95,583,000	188,000,000	451,000												64,643,000	-25,230,000	110,295,000	148,766,000	615,000	-2,955,000	-80,720,000	41,487,000	-515,580,000	-154,618,000	47,797,000	-10,833,000	-5,375,000	39,164,000	6,488,000	50,224,000							-999,000	-24,036,000	-32,833,000	-34,112,000	-3,899,000	100,526,000	-136,650,000	54,418,000	67,651,000	81,088,000	33,474,000	52,834,000	113,170,000	-125,204,000	63,563,000	55,503,000	76,197,000	51,228,000	-32,160,000				88,578,000			-19,004,000	13,584,000	28,991,000			17,686,000	7,438,000			53,383,000	25,879,000	10,553,000	-12,456,000	5,485,000	-6,368,000	1,448,000	12,713,000	14,339,000	7,106,000
cash and cash equivalents at beginning of period	0	0	0	238,361,000	0	0	0	227,891,000	0	0	0	273,710,000	0	0	0	295,278,000	0	0	0	0	0	0	0	188,701,000	0	0	0	821,935,000	0	0	0	731,434,000	0	0	0	717,249,000	0	0	0	905,730,000	0	0	0	876,048,000	0	0	0	809,541,000		0	0	735,267,000		0	0	488,776,000		0	0	415,650,000		0	0	321,078,000		0	0	257,792,000		0	0	219,544,000		0	0	142,185,000		0	0	128,907,000		0
cash and cash equivalents at end of period	276,739,000	410,767,000	95,583,000	426,361,000	451,000	27,663,000	1,147,000	209,100,000	-3,000	-25,305,000	46,036,000	207,163,000	71,941,000	7,293,000	-81,673,000	276,149,000	64,643,000	-25,230,000	110,295,000	148,766,000	615,000	-2,955,000	-80,720,000	230,188,000	-515,580,000	-154,618,000	47,797,000	811,102,000	-5,375,000	39,164,000	6,488,000	781,658,000	12,939,000	59,691,000	-163,249,000	822,053,000	-149,076,000	-14,370,000	-999,000	881,694,000	-32,833,000	-34,112,000	-3,899,000	976,574,000	-136,650,000	54,418,000	67,651,000	890,629,000		52,834,000	113,170,000	610,063,000		55,503,000	76,197,000	540,004,000		69,505,000	-26,393,000	477,824,000		6,587,000	18,411,000	302,074,000		28,991,000	27,189,000	251,314,000		7,438,000	31,513,000	201,155,000		25,879,000	10,553,000	129,729,000		-6,368,000	1,448,000	141,620,000		7,106,000
supplemental disclosure of cash flow information:
income taxes paid, net of refunds	16,178,000	-26,516,000	118,647,000	105,704,000	43,155,000	61,808,000	96,688,000	76,749,000	71,300,000	37,581,000	54,548,000	53,437,000	45,852,000	49,365,000	36,994,000	345,909,000	41,052,000	42,060,000	29,558,000	8,853,000	31,044,000	19,319,000	67,492,000	125,005,000	95,534,000	23,663,000	21,299,000	30,157,000	16,180,000	16,439,000	32,021,000	28,261,000	13,287,000	16,497,000	21,064,000	18,118,000	14,702,000	4,901,000	14,557,000	14,373,000	14,056,000	14,403,000
interest paid	6,912,000	14,218,000	-66,000	7,351,000	5,921,000	11,025,000	13,805,000	14,957,000	14,943,000	14,964,000	10,338,000	7,134,000	5,542,000	10,822,000	588,000	5,360,000	5,345,000	5,878,000	9,197,000	9,968,000	12,548,000	12,413,000	7,487,000	3,708,000	5,482,000	7,718,000	7,370,000	7,785,000	7,756,000	7,382,000	6,697,000	6,401,000	6,319,000	1,891,000	1,749,000	1,247,000	1,525,000	1,509,000	1,511,000	1,233,000	1,449,000	1,442,000	1,639,000	1,599,000	1,747,000	1,720,000	1,557,000	1,363,000		1,304,000	1,086,000	706,000		427,000	275,000	419,000		560,000	640,000	461,000		1,817,000	859,000	1,816,000		1,765,000	1,725,000	1,523,000		1,599,000	1,454,000	1,429,000		582,000	2,920,000	580,000	2,265,000	0			2,265,000	0
fair value of assets acquired, excluding cash					7,513,000	0	4,428,000	34,092,000	0	0	350,224,000	9,506,000	6,662,000	0			679,000		-3,000	11,922,000	28,718,000	57,334,000	300,663,000	42,807,000	0				4,649,000	1,292,000	2,628,000	1,891,000	213,220,000	51,573,000			1,331,000	3,906,000	7,829,000	7,342,000	0	0			0	0	-1,800,000	7,770,000			227,000	24,421,000
liabilities assumed					-2,295,000	0	-76,000	-5,325,000	16,367,000	-3,354,000	-140,803,000	-3,975,000	-2,180,000	0			1,766,000		2,000		55,706,000	-22,369,000	-256,649,000	-41,905,000					-59,000	-742,000			-20,894,000	-36,159,000			-143,000	-1,800,000	-3,417,000	-3,168,000	0	0			0	0	558,000	-2,836,000	6,850,000	0	-493,000	-11,413,000	0	0	0	-450,000	0	-532,000															712,000	0	-5,657,000	-1,871,000
goodwill on acquisition					14,479,000	0	3,296,000	74,416,000	-16,367,000	3,354,000	780,722,000	19,281,000	5,454,000	0			469,000		-175,000		-85,099,000	184,066,000	570,316,000	125,037,000	0				1,791,000	-341,000	-2,552,000	457,000	606,667,000	74,938,000			1,825,000	6,807,000	5,861,000	6,454,000	0	0			0	0	292,000	13,584,000			266,000	51,532,000				4,958,000	0	532,000			1,601,000	0			0	-20,000			0	1,000			-1,408,000	0	5,176,000	1,785,000					0	0
deferred payments					0	0			3,416,000	0	1,982,000	-2,856,000					5,449,000		176,000	-191,000	326,000	-6,716,000	-1,352,000	500,000	420,000				-921,000	1,000	94,000	742,000	226,000	175,000			-62,000	262,000	502,000	-2,405,000	680,000	0
fair value of contingent consideration	-670,000	0	670,000	855,000	0	3,079,000	0	1,293,000	469,000	0	0	-2,856,000							0			1,000											0	0			-500,000	0	-312,000	-905,000					0	0	950,000	-13,100,000									0	0
cash paid for acquisitions	138,578,000	0	670,000	855,000	19,697,000	3,079,000	7,505,000	104,476,000	3,885,000	0	992,125,000	19,100,000	6,869,000	0			8,363,000		0	24,487,000																																						0
non-cash restructuring expenses						0
accounts payable, accrued expenses, income taxes payable and other		63,090,000	4,220,000	-25,440,000		35,487,000	-34,373,000	-1,018,000		40,242,000	-17,271,000	8,041,000		27,721,000	-12,391,000	-293,303,000
patent registration and acquisition costs		-2,992,000	-2,825,000	-1,767,000		-1,918,000	-1,205,000	-10,831,000		-2,407,000	-4,319,000	-3,317,000		-3,712,000	-9,284,000	-4,453,000
proceeds (payments) on maturity of foreign currency contracts		-5,945,000	-11,803,000	18,975,000																	-4,166,000	7,029,000	551,000	-3,678,000	-10,303,000	-1,337,000	-9,403,000	6,073,000		1,876,000	-1,501,000	9,710,000
loss attributable to equity method investments, net of dividends received
previously held equity interest													0	0
loss attributable to equity method investments						-440,000	-739,000	3,895,000		184,000	2,825,000	2,028,000	2,559,000	2,627,000	1,914,000	1,386,000	1,310,000	4,967,000	5,976,000	5,296,000	6,462,000	5,996,000
gain on equity investments
net decrease in cash and cash equivalents							1,147,000	-18,791,000	-3,000	-25,305,000	46,036,000	-66,547,000		7,293,000	-81,673,000	-19,129,000																																																				-6,478,000				-18,389,000
(payments) / proceeds on maturity of foreign currency contracts								-1,501,000		11,780,000	10,223,000	-3,042,000	-11,867,000	110,000	-1,938,000	-3,481,000
proceeds from sale of investment													0
net cash (used in) / provided by financing activities										-279,557,000	932,902,000	-41,880,000				92,970,000
net cash (used in) / provided by operating activities												44,662,000				-65,657,000
changes in fair value of business combination contingent consideration																			0	0	-14,000	0	-89,000	-183,000	28,000				0	0
gain on previously held equity interest																					0
proceeds on maturity of foreign currency contracts																	-7,087,000	6,384,000
payments on maturity of foreign currency contracts																			17,780,000	-33,241,000														22,615,000	11,015,000	-39,341,000		3,068,000	-17,094,000	-11,206,000
amortization of right-of-use-assets																			6,999,000	7,201,000
impairment of equity investments																			0	9,100,000	6,206,000	5,842,000	1,248,000	1,711,000
changes in operating assets and liabilities, net of effect of acquisitions:
payment of business combination contingent consideration																													0				0	-108,000			0	0	0	-458,000	0	-675,000	0	-442,000	-6,149,000	0	0	-1,641,000
cash paid for acquisition																						212,316,000	612,810,000	126,439,000																					0	0	0	5,418,000		1,399,000	0	51,923,000	0	1,300,000	0	21,150,000
dividend paid																							-52,774,000	-52,793,000	-49,970,000	-49,974,000	-49,855,000	-49,698,000		-46,681,000	-46,487,000	-46,378,000		-41,972,000	-41,975,000	-42,079,000		-39,385,000	-39,278,000	-39,199,000		-35,262,000	-35,647,000	-35,478,000	-24,265,000	-24,251,000	-25,845,000	-22,843,000
investment in equity investments																								-2,467,000
impairment of long lived assets
impairment of cost-method investments																									7,973,000	1,366,000	1,292,000	962,000	1,367,000	382,000			0	0											250,000	0			1,717,000	0
investment in cost-method investments																									-8,050,000	-2,720,000	-500,000	-3,225,000
proceeds from disposal of cost-method investments
total cash component of purchase price																									420,000					210,000	94,000	3,090,000
gain on disposal of business
excess tax benefit from stock-based compensation arrangements																																		-2,602,000	-8,174,000	-2,536,000	-4,221,000	-9,849,000	-8,314,000	-2,575,000	-4,947,000	-1,902,000	-7,245,000	-2,241,000	-5,550,000	-4,538,000
accounts payable, accrued expenses and other liabilities																																-18,707,000	27,866,000	24,221,000	-9,346,000	3,641,000	36,079,000	23,317,000	17,998,000	8,421,000	23,938,000	17,052,000	-13,624,000	-24,267,000	49,635,000	-9,170,000	2,457,000	-13,293,000		20,640,000	2,114,000	24,049,000		-740,000	4,300,000	-19,161,000		27,641,000	-38,856,000	9,696,000		8,352,000	24,571,000	-3,188,000		-19,511,000	-23,845,000	-12,263,000		5,437,000	8,749,000	-8,516,000	15,262,000	1,294,000	-1,626,000	-204,000			5,838,000	1,321,000	-2,712,000	16,154,000
investments in cost-method investments																															-1,109,000	-2,758,000	-750,000	-633,000	-3,000,000	-4,582,000	-250,000	0	-10,000,000	-500,000	-5,575,000	-3,750,000	-850,000	-675,000	-667,000	-667,000
purchases of foreign currency contracts
(payment)/proceeds on maturity of foreign currency contracts
impairment of long-lived assets																																		0																0	0	0		0	0	2,257,000
purchase of investments
net cash (used in) from financing activities																																-40,048,000
gain on divestment of business																																						0	0	-709,000
proceeds from divestiture of business																																						0	0	468,000
net increase/(decrease) in cash and cash equivalents																																		59,691,000																									-26,393,000	62,174,000
total purchase price, excluding contingent consideration																																						9,175,000	10,463,000	7,318,000	680,000	0			0	0	0	5,418,000
net (decrease)/increase in cash and cash equivalents																																				104,804,000
foreign currency revaluation																																						-1,642,000	-61,000	451,000	-2,947,000	-5,275,000	3,623,000	-1,653,000	11,986,000	-5,351,000	1,364,000	-1,741,000	-4,888,000	740,000	-12,274,000	2,770,000	-3,869,000	-1,100,000	-4,773,000	-7,519,000	1,534,000	-3,548,000	-1,924,000	-3,349,000		403,000	3,336,000	16,811,000
purchases of foreign currency options																																										-932,000				-95,000	-98,000	-402,000		-1,270,000	0	0		-920,000	-430,000	-113,000		-393,000	-195,000	-891,000		-564,000	-556,000	-154,000	-985,000
gain on previously held equity interest resulting from business combination																																																	0	0	0	-2,070,000
purchases of other intangible assets																																																	0	0	0	-7,000,000
proceeds from exercise of foreign currency contracts
less: consideration not paid in the current period																																																	0	1,399,000	0	-12,617,000
(payments)/proceeds from exercise of foreign currency contracts
(payments)/proceeds from exercise of foreign currency options																																											-1,593,000	-2,486,000
proceeds from borrowings																																												60,000,000	60,000,000	40,000,000	35,000,000	15,000,000			95,384,000	80,000,000
income taxes paid																																												39,612,000		18,137,000	19,669,000	24,565,000		6,366,000	17,561,000	4,294,000		20,655,000	21,261,000	22,293,000				8,679,000				2,227,000		16,319,000	13,804,000	1,198,000		13,387,000	22,520,000	13,007,000		8,175,000	15,765,000	10,980,000		7,146,000	6,181,000	6,689,000	5,505,000	-1,121,000
proceeds from sale of maturing investment securities																																																	0	0	0	0	0	0	0	3,950,000	0	50,000
proceeds from exercise of foreign currency options																																														751,000	3,031,000	5,703,000		8,461,000	2,069,000	2,967,000		4,581,000	5,621,000	4,368,000		3,485,000	4,418,000	2,901,000		0	0	814,000	3,451,000
tax benefit from stock option exercises																																																-3,760,000	12,625,000	-2,081,000	-940,000	-856,000	26,076,000	-3,016,000	-6,153,000	-2,397,000	21,311,000	-2,979,000	-7,232,000	2,069,000	7,255,000	-1,945,000	-370,000	-1,070,000	7,140,000	-530,000	-1,740,000	-1,057,000	23,688,000	-3,920,000	-5,824,000	-1,546,000	7,580,000	244,000	469,000	1,460,000
purchases of cost-method investments																																																			-3,631,000	-1,165,000				-1,166,000					-1,368,000
adjustments to reconcile net income to net cash from operating activities:
benefit from warranties																																																																			709,000	430,000			209,000	577,000
deferred income taxes
tax benefit from stock options exercised																																																												-2,069,000
impairment of long lived asset
prepaid expenses and other current assets																																																																															-556,000	371,000	1,062,000	-1,120,000
accounts payable, accrued expenses, income taxes and other liabilities
proceeds from disposal of cost method investment
proceeds from disposal of business assets and contracts																																																					0				170,000				1,243,000	321,000	0	1,441,000
cash and cash equivalents at beginning of the year
cash and cash equivalents at end of the year
interest paid, net of capitalized interest
fair value of assets acquired in acquisitions, excluding cash																																																	0				0	1,300,000	0	17,142,000	0	0
total purchase price																																																	0	0	0	64,540,000	0	1,300,000	0	21,650,000
benefit from product warranties																																																						-565,000	-600,000	682,000		-255,000	987,000	1,509,000		1,098,000	635,000	375,000
purchase of cost-method investments																																																						-660,000
net cash (used in) financing activities																																																				-83,943,000
goodwill on acquisition fair value of contingent consideration																																																						800,000
write-down of cost-method investments																																																					0	0	0	0	0	0	0	250,000	0	201,000			0
proceeds from disposal of property, plant and equipment
capitalized interest																																																													-116,000	-293,000	-641,000	-560,000	-381,000	-295,000	-363,000	-194,000	-61,000	0	0	-351,000	-461,000	-298,000	-217,000	-124,000
less: deposit paid in previous period																																																					0	0	0	-500,000
purchase of intangible assets
net cash (used in)/provided by financing activities																																																							-1,967,000	-36,484,000		18,943,000	-22,411,000	-18,009,000
amortization of deferred borrowing costs																																																								0			1,000	280,000	44,000	404,000	32,000	78,000	43,000	41,000	-18,000	99,000	35,000	38,000	39,000	81,000	20,000	157,000	202,000	270,000	218,000	205,000	206,000	205,000		193,000
business acquisitions																																																								-21,150,000					-2,072,000	0
voluntary product recall expenses																																																																					0
gain on sale and leaseback of real property
purchases of investment securities																																																																	0
business acquisitions, net of cash acquired of 1,260																																																									0	0
cash paid for acquisition, including acquisition costs																																																																								323,000				2,483,000
proceeds from disposals of property, plant and equipment
income taxes paid/
foreign currency options revaluation																																																																	-3,178,000	-908,000	833,000	-776,000	-340,000	-104,000	-1,300,000	653,000	-206,000	1,798,000	1,675,000	529,000			-690,000	-366,000
fair value of assets acquired in acquisitions																																																																									1,175,000	0
acquisition costs accrued																																																																									-480,000	0
gain on sale and lease back of real property
proceeds from sale of investment securities
net cash provided by/(used in) financing activities																																																														-8,887,000	17,903,000	387,000
cash paid for acquisitions, including acquisition costs																																																														0								1,332,000	903,000	-323,000		1,271,000	11,842,000	-2,483,000						0
purchases of cost-method investment
proceeds from borrowing																																																															50,000,000	21,000,000
net acquisition costs accrued																																																																						1,331,000
purchase of cost-method investment																																																																-899,000
business acquisitions, net of cash acquired of nil
repayment of assumed borrowings from acquisitions																																																																									0	1,000	-1,727,000	-469,000
acquisition costs paid																																																																									159,000	1,271,000
changes in operating assets and liabilities; net of effect of acquisitions:
cash paid for business acquisitions, net of cash acquired of nil in 2008 and nil in 2007
proceeds from sale or maturity of investment securities
purchases of non trading investments
proceeds from sale of marketable securities–available-for-sale
purchases of marketable securities–available-for-sale																																																																			0	-6,500,000
prepaid expenses, deferred income taxes and other current assets																																																																				-896,000				-6,396,000				-4,549,000
purchases of non-trading investments																																																																				-432,000				-631,000				-612,000				-186,000
fair value of assets acquired in acquisition																																																																												2,552,000
net acquisition costs paid																																																																								323,000				17,000
impairment of cost-method investment
release of profit on sale of building
purchased in-process research and development write-off
purchases of marketable securities—available for sale
proceeds from sale of marketable securities—available for sale
write-down of cost-method investment																																																																										626,000
purchase of non trading investments																																																																						-69,000
cash paid for business acquisitions, net of cash acquired of nil in 2007 and 262 in 2006
purchases of marketable securities available-for-sale
proceeds from sale or maturity of marketable securities – available-for-sale																																																																														175,055,000
cash paid for acquisitions, net of cash acquired of nil
purchases of marketable securities – available-for-sale
purchases of marketable securities—available-for-sale																																																																								-20,000,000
business acquisitions, net of cash acquired of 262																																																																									-158,000	-1,271,000
profit on sale and lease-back of building																																																																														-668,000	-653,000	-611,000		-656,000
purchase of non-trading investments																																																																										-934,000				-1,017,000				-464,000
purchases of marketable securities-available-for-sale
purchase of treasury stock																																																																														0	0	-10,965,000		0
benefit from service warranties																																																																											140,000	277,000			571,000	107,000	52,000	58,000
purchases of marketable securities - available-for-sale																																																																												-4,499,000				-46,841,000
proceeds from sale or maturity of marketable securities-available-for-sale																																																																																56,130,000
gain on extinguishment of debt
purchased in-process research and development write off
purchases of marketable securities - available for sale
proceeds from sale of marketable securities - available for sale
business acquisitions, net of cash acquired of 12,982
proceeds from sale of non-trading investments
redemption of borrowings, convertible note
installment payment for property purchase
foreign currency options revaluations																																																																																		191,000
other operating assets and liabilities
acquisition of businesses, net of cash acquired of 2,450
proceeds from sales of non-trading investments
redemption of borrowings
by operating activities:
deferred borrowing costs
other
proceeds from sale-leaseback
fair value of shares issued for acquisitions
gain on debt extinguishment
proceeds from sale of marketable securities – available-for-sale
fair value of assets acquired on acquisition:
repayment for property purchase
fair value of assets acquired on acquisition

We provide you with 20 years of cash flow statements for ResMed stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ResMed stock. Explore the full financial landscape of ResMed stock with our expertly curated income statements.

The information provided in this report about ResMed stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.